Clinical Trial Update: Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery [Phase 2]

View source ↗

Summary

Phase 2 multinational trial evaluated the effect and safety of recombinant factor XIII (rFXIII) on transfusion needs in patients undergoing heart surgery. Resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Bleeding Disorders

Drugs mentioned

• Recombinant Factor XIII (rFXIII) (Factor XIII, recombinant)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass | Phase 2 | Status: COMPLETED | Results posted: 2014-11-13